Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Effectiveness of intravenous tocilizumab in routine clinical practice in a cohort of Costa Rican patients with rheumatoid arthritis
Mauricio Cordero-Alfaro; Carlos León-Céspedes; Allan Ramos-Esquivel;
Reumatol Clin. 2021;17:329-34
Efficacy and safety of combined therapy with synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: Systematic literature review
Jaime Calvo Alén; Trinidad Pérez; Susana Romero Yuste; Iván Ferraz-Amaro; Juan José Alegre Sancho; José Antonio Pinto Tasende; Francisco Maceiras Pan; Juan Carlos Quevedo; M. Vanesa Hernández-Hernández; Cristina Hidalgo Calleja; Alejandro San Martín Álvarez; María Isabel Tevar Sánchez; Raimon Sanmartí;
Reumatol Clin. 2020;16P1:324-32
Fibromyalgia with elevated rheumatoid factor is associated with poor therapeutic response but not with progression to rheumatoid arthritis. Prospective cohort study
Freddy Liñán Ponce; Juan Leiva Goicochea; David Sevilla Rodríguez; Elmer Hidalgo Bravo; Ginna Obregón Atanacio; Inés Loyola Macalapú; Paola Jáuregui Rojas; Jackeline Yampufe Canani;
Reumatol Clin. 2024;20:459-62